Meitheal Reveals Manufacturing Expansion Plans
Increasing Capacity To Produce Heparin Amid Supply Concerns
Meithal Pharmaceuticals has revealed future plans to expand its manufacturing capabilities as the US FDA approved a new vial manufacturing line that will double the firm’s capacity to supply the US market.
